PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97783480 |
Filing Date: 02/07/2023 |
Input Field |
Entered |
SERIAL NUMBER | 97783480 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\977\834\97783480\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
COLOR MARK | NO |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of a circle containing an abstract geometric design. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 373 x 457 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Merative US L.P. |
*MAILING ADDRESS | 100 Phoenix Drive |
*CITY | Ann Arbor |
*STATE (Required for U.S. applicants) |
Michigan |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
48108 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | limited partnership |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 009 |
*IDENTIFICATION | Downloadable software for collecting, organizing, managing, analyzing, and reporting the results of clinical trials, clinical studies, and clinical tests from global trials sites and trial participants |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Software as a service (SaaS) and platform as a service (PaaS) providing access to online software for collecting, organizing, managing, analyzing, and reporting the results of clinical trials, clinical studies, and clinical tests from global trials sites and trial participants; providing delivery and enablement services concerning the results of clinical trials, clinical studies, and clinical tests |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 044 |
*IDENTIFICATION | Consulting services concerning clinical trials, clinical studies, and clinical tests; providing data to healthcare professionals concerning clinical trials, clinical studies, and clinical tests; providing a website featuring information for parties conducting and participating in clinical trials and clinical studies |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Sean Ploen |
ATTORNEY DOCKET NUMBER | MTV-645 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Ploen Law Firm, P.C. |
STREET | 724 Bielenberg Drive, #19 |
CITY | Saint Paul |
STATE | Minnesota |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 55125 |
PHONE | 651-894-6800 |
FAX | 651-894-6801 |
EMAIL ADDRESS | docketing@ploen.com |
CORRESPONDENCE INFORMATION | |
NAME | Sean Ploen |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | docketing@ploen.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | sploen@ploen.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 3 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 1050 |
*TOTAL FEES PAID | 1050 |
SIGNATURE INFORMATION | |
SIGNATURE | /julie daughtry/ |
SIGNATORY'S NAME | Julie Daughtry |
SIGNATORY'S POSITION | Chief Legal Officer |
SIGNATORY'S PHONE NUMBER | 000-000-0000 |
DATE SIGNED | 02/07/2023 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97783480 |
Filing Date: 02/07/2023 |
The applicant's current Correspondence Information: |
Sean Ploen |
PRIMARY EMAIL FOR CORRESPONDENCE: docketing@ploen.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sploen@ploen.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|